Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer

Recruiting

Brief Summary: The overarching goal of the proposed study is to provide information which can lead to effective implementation of cessation support in the care of smokers diagnosed with lung or head \& neck cancer.

To achieve these aims, the study propose to conduct a longitudinal cohort study of patients diagnosed with lung or head \& neck cancer at the Hospices Civils de Lyon (SMALLHAN). Briefly, adult patients newly diagnosed with lung or head \& neck cancer will be recruited at the time of diagnosis (announcement of diagnosis and consultation).

Recruitment & Eligibility

Inclusion Criteria

Patients newly diagnosed with lung cancer or head & neck cancer (International Classification of Diseases 10: C76, C34)
Patients who undergo front-line treatment
Age 18 years or older
Benefiting from a Social Security scheme
Written information about the study provided to the patient before any procedure specific to the study
Patients who had at least one episode of smoking within the past 30 days before diagnosis

Exclusion Criteria

History of another lung or head & neck cancer < 5 years (Note: The presence of a second tumour location, discovered at the same time as the lung or head and neck cancer, does not constitute a non-inclusion criterion)
History of another cancer (except for curatively treated cervical cancer in situ and non-melanoma skin cancer) < 3 years
Mesothelioma, thymic malignancies, and cancer of the upper oesophagus
Inability to complete the study for psychosocial reasons (inability to schedule interview (homeless), no access to phone, psychological disorder leading to inability to answer phone interview, do not speak French and no easy access to translator from surroundings)
Patient under guardianship
Patient refusal

Arm && Interventions

Group	Intervention	Description
Patients newly diagnosed with lung cancer or head & neck cancer	questionnaire	Patients newly diagnosed with lung cancer or head \& neck cancer (International Classification of Diseases 10: C76, C34) who undergo front-line treatment and who had at least one episode of smoking within the past 30 days before diagnosis

Primary Outcome Measures

Name	Time	Method
Change of odds ratios and corresponding 95% confidence intervals for non-use of cessation services evaluated by questionnaire(0=non-use of service, 1=use of service)	Baseline and 3, 6 and 12 months
Description of socio-professional determinants obtained by questionnaire	Baseline	specific questionnaires querying demographics, socio-professional status, cessation or reduction attempts, and motivation and barriers to cessation, psychiatric conditions including level of addiction and depression.
Description of accessibility-related determinants obtained by questionnaire	Baseline	specific questionnaire querying travel time, distance, means of transportation used to access the hospital or cessation services
Change of odds ratios and corresponding 95% confidence intervals for continuation or relapse of tobacco use or dual use of tobacco and alcohol evaluated by questionnaire (0=abstinent, 1=continuation or relapse)	Baseline and 3, 6 and 12 months

Secondary Outcome Measures

Name	Time	Method

Locations (4): Hôpital Louis Pradel, Pneumologie
🇫🇷
Bron, France
Hôpital de la Croix-Rousse, Oto-Rhino-Laryngologie et Chirurgie Cervico-Faciale
🇫🇷
Lyon, France
Hôpital de la Croix-Rousse, Pneumologie
🇫🇷
Lyon, France
Hôpital Lyon Sud, Pneumologie
🇫🇷
Pierre-Bénite, France

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial